Lyn Baranowski

Insider Reports History

Location
San Jose, CA
Signature
/s/ Douglas Carlson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lyn Baranowski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avalyn Pharma Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 501,033 29 Apr 2026 Direct
Rani Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 22,240 25 May 2022 Direct

Insider Reports Filed by Lyn Baranowski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVLN Avalyn Pharma Inc. 29 Apr 2026 1 $0 4 Chief Executive Officer, Director 01 May 2026, 18:25
AVLN Avalyn Pharma Inc. 29 Apr 2026 0 $0 3 Chief Executive Officer, Director 29 Apr 2026, 18:23
RANI Rani Therapeutics Holdings, Inc. 25 May 2022 1 $0 4 Director 27 May 2022, 08:30
RANI Rani Therapeutics Holdings, Inc. 10 Nov 2021 1 $0 4 Director 12 Nov 2021, 17:32
RANI Rani Therapeutics Holdings, Inc. 10 Nov 2021 0 $0 3 Director 12 Nov 2021, 17:28
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .